{"transactions":[{"id":722535,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":34397,"kind":"person","name":"Fu Wei","position":1,"cik":"0001885756","reported_name":"Fu Wei","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-30T20:15:24.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":1010100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ADS."},{"field":"shares","element":"transactionShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vest over two years in equal annual installments on June 29, 2027 and June 29, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vest over two years in equal annual installments on June 29, 2027 and June 29, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."}],"balance_after":1010100,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1010100},"source":{"system":"sec-edgar","filing":"0001885756-26-000005","document":"form4-06302026_040618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000188575626000005/form4-06302026_040618.xml","form_type":"4"}},{"id":722534,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":34397,"kind":"person","name":"Fu Wei","position":1,"cik":"0001885756","reported_name":"Fu Wei","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"2025 Employee Share Option (right to buy)","published_at":"2026-06-30T20:15:24.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":1087720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests, if at all, in eight equal quarterly installments following the date on which the 30-trading-day weighted average price of the Issuer's ADS (based on trading days only) is at or above US$16.00."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."}],"balance_after":1087720,"derivative":{"exercise_price":2.45,"expiration_date":"2036-06-29","underlying":"Ordinary Shares","underlying_shares":1087720},"source":{"system":"sec-edgar","filing":"0001885756-26-000005","document":"form4-06302026_040618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000188575626000005/form4-06302026_040618.xml","form_type":"4"}},{"id":722533,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":34397,"kind":"person","name":"Fu Wei","position":1,"cik":"0001885756","reported_name":"Fu Wei","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"2025 Employee Share Option (right to buy)","published_at":"2026-06-30T20:15:24.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":1087720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests, if at all, in eight equal quarterly installments following the date on which the 30-trading-day weighted average price of the Issuer's ADS (based on trading days only) is at or above US$12.00."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."}],"balance_after":1087720,"derivative":{"exercise_price":2.45,"expiration_date":"2036-06-29","underlying":"Ordinary Shares","underlying_shares":1087720},"source":{"system":"sec-edgar","filing":"0001885756-26-000005","document":"form4-06302026_040618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000188575626000005/form4-06302026_040618.xml","form_type":"4"}},{"id":722532,"issuer":{"id":6324,"kind":"organization","name":"NovaBridge Biosciences","symbol":"NBP"},"owners":[{"id":34397,"kind":"person","name":"Fu Wei","position":1,"cik":"0001885756","reported_name":"Fu Wei","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"2025 Employee Share Option (right to buy)","published_at":"2026-06-30T20:15:24.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":725140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests, if at all, in eight equal quarterly installments following the date on which the 30-trading-day weighted average price of the Issuer's ADS (based on trading days only) is at or above US$8.00."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Number of underlying securities and exercise price expressed in terms of American Depositary Shares (\"ADS\")."}],"balance_after":725140,"derivative":{"exercise_price":2.45,"expiration_date":"2036-06-29","underlying":"Ordinary Shares","underlying_shares":725140},"source":{"system":"sec-edgar","filing":"0001885756-26-000005","document":"form4-06302026_040618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778016/000188575626000005/form4-06302026_040618.xml","form_type":"4"}}]}